Quarterly Results

Quarterly Results

2010

Hide / Show

	2010 Annual Report 558.6 KB
	Proxy Statement 258.2 KB
	Proxy Card 25.6 KB

2009

Hide / Show

	2009 Annual Report 566.0 KB
	Proxy Statement 428.9 KB
	Proxy Card 30.0 KB

2008

Hide / Show

	2008 Annual Report 467.7 KB
	Proxy Statement 210.7 KB
	Proxy Card 30.1 KB

2007

Hide / Show

	2007 Annual Report 1.4 MB
	Proxy Statement 1.0 MB

2006

Hide / Show

	2006 Annual Report 781.5 KB
	Proxy Statement 223.0 KB

Add to Briefcase

= add file to Briefcase

Stock Quote
CADX - (NASDAQ) $4.27 + 0.05 Feb 3, 2012 4:00 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.

"We hold ourselves accountable for possessing and maintaining high
standards of quality and uncompromised ethics." Ted Schroeder

News Room

Nov 22, 2011 Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters Nov 15, 2011 Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock Read more

Core Values

At Cadence, we are guided by a set of core values that communicate what is most important to us. Performance Driven Transparency Integrity Respect

Home Products People Our Focus Working at Cadence Investors Careers Contact Us Terms of Use Corporate Compliance Privacy policy

© 2012 Cadence Pharmaceuticals Inc. All rights reserved.